Cell therapy
for every
patient in need
Automating the manufacture of CAR T-cells
Our Mission
Transforming Cancer Care
At BioOra, we believe New Zealanders deserve timely access to the world’s most advanced cancer treatments. Our mission is to reduce the barriers that keep CAR T-cell therapy out of reach for many patients. By combining scientific innovation with manufacturing automation, we’re working to make personalised cell therapy safer, faster, and more affordable.
Our Platform
Advanced Manufacturing for Cell Therapies
Traditional CAR T-cell manufacturing is complex and resource-intensive. BioOra’s semi-automated GMP platform streamlines this process—minimising manual handling, reducing costs, and enabling consistent quality.
This technology gives us the flexibility to:
Manufacture therapies for clinical trials and commercial supply
Scale rapidly to meet growing patient demand
Support multiple CAR T-cell constructs from different partners
We’re not just making one therapy. We’re building an ecosystem for the future of cancer treatment in New Zealand and Australia.
Our Clinical Work
Pioneering Local CAR T-cell Access
We currently hold the commercial rights to a clinical-stage CAR T-cell therapy undergoing Phase II trials in New Zealand. This trial represents a significant step toward making advanced immunotherapy available locally—so patients can receive cutting-edge treatment close to home, rather than travelling overseas.
As we look ahead, our platform will support additional CAR T-cell products in partnership with innovators worldwide, helping bring more therapeutic options to patients across Australasia.
BioOra Limited is not a provider of health services and does not recruit patients to clinical trials directly. Patients should speak with their haematologist or oncologist about whether this, or other conventional or clinical trials, might be an option for them. Referrals must be made by a relevant specialist to a trial investigator.
A public summary of the ENABLE-2 trial is available on the ClinicalTrials.gov website.
Our Vision
A Future Where Innovation Meets Access
Cancer doesn’t wait—and neither should patients. At BioOra, we’re working toward a future where advanced cell therapies are part of standard cancer care in New Zealand. By reducing costs, shortening manufacturing timelines, and building strategic partnerships, we’re creating a pathway for broader access to life-changing treatments.
Together, we can give more patients a fighting chance.
Explore our Facilities
“It is exciting to make this transformative therapy accessible to patients from around the world and be a part of bringing new CAR T-cell products to the clinic.”
— Saum Vahdat, Director
